about
The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2Chemoresistance and targeted therapies in ovarian and endometrial cancersARID1A Is Essential for Endometrial Function during Early PregnancyMolecular cues on obesity signals, tumor markers and endometrial cancer.PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy.3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.Fenretinide: a novel treatment for endometrial cancer.High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.Progesterone action in breast, uterine, and ovarian cancers.Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence.Cornual polyps of the fallopian tube are associated with endometriosis and anovulation.Influence of AKT on progesterone action in endometrial diseases.Effects of female sex hormones on clusterin expression and paclitaxel resistance in endometrial cancer cell linesMig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer.microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAsResponse-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.An aggregated analysis of hormonal factors and endometrial cancer risk by parityCritical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapyManagement of endometrial precancers.Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma.Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I.Spontaneous conception in 40-year-old infertile woman with polycystic ovaries after complete reversal of endometrial intraepithelial neoplasia: A case report with review of literature.Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model.United States medical eligibility criteria for contraceptive use 2010: a review of changes.Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.The role of progesterone and its receptor on cyclin G1 expression in endometrial carcinoma cells.Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.
P2860
Q24602570-F8C6CA32-9AEB-4D66-BB2C-92F3DC08C821Q28073246-C2F98CAB-65A5-4E17-848F-3D6BA339F896Q30370823-F7C906D9-1CF8-4225-B452-FEADCDCC2E19Q30372789-5A8E7066-C71E-40C3-BB82-AE8B88E765DCQ33813234-62ED7F23-8306-4FAE-88CD-E1328731213EQ33936933-D8D53A8F-7DAB-4912-A5DC-66F86F971AB8Q34147704-1A07B376-0A75-42C8-BFFC-3CF2931A16CAQ34180982-59A912D5-BE43-4CEE-83AC-A511E52B0FDBQ34182662-D9F3C42C-2018-4381-80D8-ADA0489830D8Q34305296-55522B51-9F18-4040-BF3F-9F83DDA14D50Q34321877-24E341BD-9A7F-4D06-9965-BB780FA5C719Q34388048-4D061767-18B9-4200-A826-60CDC7C9EF9BQ34395170-DB9F9039-3A80-4A78-B51D-EEF011B948F3Q34727321-EFB97F05-04B7-4823-AF98-E44B48B2183AQ35097256-17F4F421-D118-43FA-B6B9-1AC519B7C1ACQ35108906-39112F50-0C88-49EE-B785-78BA937A48B0Q35286790-941DC5E5-5DA0-4AED-8462-546C6D7D199AQ35608945-ED8D2615-5BDE-4AA7-8D03-0C1AF038575BQ35617565-9CB9F789-DDE3-4BBB-81C7-CA46B59262A8Q35632043-CEC43A5E-2A7A-4051-BB0D-E78E730965C2Q35706738-9DC4AC63-288D-4F35-867A-C3095AAE35F6Q35926568-3B4E5471-5776-4BDE-884C-99500C424A32Q36069742-6193A28D-EEAA-4C41-9B76-FAEC867E44AAQ36190111-A8D8FCD2-DC72-4430-B25A-AFF96F316DEEQ36456399-70906179-45B6-4B6B-AD09-97A1F1D0C5B0Q36475922-94BD1D16-ABA8-4617-84B8-06D9343ED9A0Q36661765-E9DAE6CA-3E03-4510-9F36-EC6B110FEEDAQ37097950-5346EB0A-6C1F-4F4C-B9C9-1D663C10667EQ37100117-D7DAC91D-3D29-47E8-BD90-13DEEA961281Q37118392-78D50C9F-3109-44CB-BEF3-C44B0E88BA10Q37238537-1DAB8F1A-4FD0-49C2-BC7B-1555597E7CDDQ37406760-74F9590F-85D8-40A0-A913-C89455392EF0Q37620151-FE35974B-5DCD-4DCA-AE79-CAD064A0C4A5Q37630613-94EF116E-887B-485C-80F9-2851C46F4447Q37709290-C4CC0BDC-77BA-49A5-AB8F-4C64AD223450Q37953522-79EEE5B0-D1EE-4CEA-AA1E-6EAE5F326CF7Q38829318-35DC2877-632F-42BA-A6FA-502EB8458CB0Q39339376-EA66A918-1777-4925-870A-F293BF64A09BQ39612459-FE924AEE-CE34-46DE-9040-517325B7CEF6Q40995588-52939A4B-2C1E-455D-A538-FBD0271A9B28
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of progesterone in endometrial cancer
@ast
Role of progesterone in endometrial cancer
@en
Role of progesterone in endometrial cancer
@nl
type
label
Role of progesterone in endometrial cancer
@ast
Role of progesterone in endometrial cancer
@en
Role of progesterone in endometrial cancer
@nl
prefLabel
Role of progesterone in endometrial cancer
@ast
Role of progesterone in endometrial cancer
@en
Role of progesterone in endometrial cancer
@nl
P2860
P356
P1476
Role of progesterone in endometrial cancer
@en
P2093
Eloise Chapman-Davis
J Julie Kim
P2860
P356
10.1055/S-0029-1242998
P577
2010-01-26T00:00:00Z